The combined oral contraceptive pill (COCP) has been a popular choice of contraception since it was first introduced in 1961. There are numerous varieties of COCP and tailored regimes allow patients more choice and opportunities to adapt contraception to suit individual needs. The pandemic has made it more difficult for patients to access long-acting reversible contraception support and many have been using interim methods of contraception, including the COCP. In this article we explore which pill to prescribe, developments in tailored regimes, guidance about changing pills when side effects arise, health risks and benefits, as well as best practice for remote assessments and prescribing.
BNF (2021) Available at: bnf.nice.org.uk (accessed 12 March 2021).
4.
DragomanMVTepperNKFuR, et al. (2018) A systematic review and meta-analysis of venous thrombosis risk among users of combined oral contraception. International Journal of Gynaecology and Obstetrics141(3): 287–294. DOI: 10.1002/ijgo.12455.
5.
FSRH (2016) UK medical eligibility criteria for contraceptive use. Available at: www.fsrh.org/ukmec/ (accessed 11 March 2021).
Iversen L, Sivasubramaniam S, Lee AJ, et al. (2017) Lifetime cancer risk and combined oral contraceptives: The Royal College of General Practitioners’ Oral Contraception Study. American Journal of Obstetrics & Gynecology 216(6): 580.e1–580.e9. DOI: 10.1016/j.ajog.2017.02.002.
12.
NICE (2017) Endometriosis diagnosis and management. Available at: www.nice.org.uk/guidance/NG73 (accessed 12 March 2021).
RCOG (2016) Green top guideline no.48: Premenstrual syndrome management. Available at: rcog.org.uk/en/guidelines-research-services/guidelines/gtg48 (accessed 12 March 2021).
